logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11357747 B1

PDFFull Text
Date of Patent:
Jun. 14, 2022

Filed:

Aug. 07, 2020

Amino acid compositions for the amelioration of symptoms of hangover

Applicants:

Entrinsic, Inc., Norwood, MA (US);

University of Florida Research Foundation, Incorporated, Gainesville, FL (US);

Inventors:

Sadasivan Vidyasagar, Gainesville, FL (US);

Stephen J. Gatto, Norwood, MA (US);

Daniel B. Dennison, Tallahassee, FL (US);

Assignees:

ENTRINSIC, INC., Norwood, MA (US);

UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED, Gainesville, FL (US);

Attorney:

Greenberg Traurig, LLP

Primary Examiner:

Savitha M Rao

Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 31/197 (2006.01); A61K 31/405 (2006.01); A61K 31/00 (2006.01); A61P 1/00 (2006.01); A61P 1/12 (2006.01); A61P 3/12 (2006.01); A61P 29/00 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A61K 31/197 (2013.01); A61K 31/405 (2013.01); A61P 1/00 (2018.01); A61P 1/12 (2018.01); A61P 3/12 (2018.01); A61P 29/00 (2018.01); A61P 31/12 (2018.01); A61P 31/18 (2018.01); A61P 35/00 (2018.01); A61K 31/00 (2013.01);
Abstract

The subject invention provides therapeutic compositions, and uses thereof for the treatment or amelioration of symptoms of a disease selected from the group consisting of: Ebola virus infection, HIV infection, ataxia, environmental enteropathy, cancer, hangover, inflammatory disease, and porcine epidemic diarrhea. In preferred embodiments, the composition includes a combination of one or more amino acids selected from the group comprising lysine, aspartic acid, glycine, isoleucine, threonine, tyrosine, valine, tryptophan, asparagine and/or serine.

Find Patent Forward Citations

Loading…